BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27048276)

  • 1. Influence of Primary Ligands (ODA, TDA) on Physicochemical and Biological Properties of Oxidovanadium (IV) Complexes with Bipy and Phen as Auxiliary Ligands.
    Pranczk J; Tesmar A; Wyrzykowski D; Inkielewicz-Stępniak I; Jacewicz D; Chmurzyński L
    Biol Trace Elem Res; 2016 Nov; 174(1):251-258. PubMed ID: 27048276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical properties of ternary oxovanadium(IV) complexes with oxydiacetate and 1,10-phenanthroline or 2,2'-bipyridine. Cytoprotective activity in hippocampal neuronal HT22 cells.
    Wyrzykowski D; Inkielewicz-Stępniak I; Pranczk J; Żamojć K; Zięba P; Tesmar A; Jacewicz D; Ossowski T; Chmurzyński L
    Biometals; 2015 Apr; 28(2):307-20. PubMed ID: 25656562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
    León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
    J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, physicochemical and biological properties of new complex salt of aqua-(nitrilotriacetato-N,O,O',O")-oxidovanadium(IV) anion with 1,10-phenanthrolinium cation.
    Tesmar A; Inkielewicz-Stępniak I; Sikorski A; Wyrzykowski D; Jacewicz D; Zięba P; Pranczk J; Ossowski T; Chmurzyński L
    J Inorg Biochem; 2015 Nov; 152():53-61. PubMed ID: 26349013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
    D'Cruz OJ; Dong Y; Uckun FM
    Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
    Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
    Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.
    Banerjee A; Dash SP; Mohanty M; Sanna D; Sciortino G; Ugone V; Garribba E; Reuter H; Kaminsky W; Dinda R
    J Inorg Biochem; 2019 Oct; 199():110786. PubMed ID: 31377474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Series of Green Oxovanadium(IV) Precatalysts with O, N and S Donor Ligands in a Sustainable Olefins Oligomerization Process.
    Urbaniak M; Pobłocki K; Kowalczyk P; Kramkowski K; Drzeżdżon J; Gawdzik B; Świtała P; Miler M; Heleniak D; Rybiński P; Jacewicz D
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant capacity and DNA-interaction studies of zinc complexes with a non-steroidal anti-inflammatory drug, mefenamic acid.
    Tarushi A; Karaflou Z; Kljun J; Turel I; Psomas G; Papadopoulos AN; Kessissoglou DP
    J Inorg Biochem; 2013 Nov; 128():85-96. PubMed ID: 23948577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
    Le M; Rathje O; Levina A; Lay PA
    J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
    Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
    J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiodiacetate-manganese chemistry with N ligands: unique control of the supramolecular arrangement over the metal coordination mode.
    Grirrane A; Pastor A; Galindo A; Alvarez E; Mealli C; Ienco A; Orlandini A; Rosa P; Caneschi A; Barra AL; Sanz JF
    Chemistry; 2011 Sep; 17(38):10600-17. PubMed ID: 21834105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
    Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
    Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin.
    Naso LG; Valcarcel M; Roura-Ferrer M; Kortazar D; Salado C; Lezama L; Rojo T; González-Baró AC; Williams PA; Ferrer EG
    J Inorg Biochem; 2014 Jun; 135():86-99. PubMed ID: 24681549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single crystal EPR study of the dinuclear Cu(II) complex [Cu(tda)(phen)](2)·H(2)tda (tda = thiodiacetate, phen = phenanthroline): influence of weak interdimeric magnetic interactions.
    Neuman NI; Perec M; González PJ; Passeggi MC; Rizzi AC; Brondino CD
    J Phys Chem A; 2010 Dec; 114(50):13069-75. PubMed ID: 21117655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
    Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
    Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Antioxidant Activity and Ligand Basicity in the Dipicolinate Series of Oxovanadium(IV) and Dioxovanadium(V) Complexes.
    Drzeżdżon J; Pawlak M; Matyka N; Sikorski A; Gawdzik B; Jacewicz D
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
    Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
    J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.